SI1697005T1 - Kombinacija flupirtina in tramadola - Google Patents
Kombinacija flupirtina in tramadolaInfo
- Publication number
- SI1697005T1 SI1697005T1 SI200431786T SI200431786T SI1697005T1 SI 1697005 T1 SI1697005 T1 SI 1697005T1 SI 200431786 T SI200431786 T SI 200431786T SI 200431786 T SI200431786 T SI 200431786T SI 1697005 T1 SI1697005 T1 SI 1697005T1
- Authority
- SI
- Slovenia
- Prior art keywords
- flupirtine
- tramadol
- combination
- treament
- pain
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US52976103P | 2003-12-17 | 2003-12-17 | |
| PCT/EP2004/014025 WO2005058420A1 (en) | 2003-12-17 | 2004-12-09 | Combination of flupirtine and tramadol |
| EP04803682A EP1697005B1 (en) | 2003-12-17 | 2004-12-09 | Combination of flupirtine and tramadol |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SI1697005T1 true SI1697005T1 (sl) | 2012-01-31 |
Family
ID=34700037
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SI200431786T SI1697005T1 (sl) | 2003-12-17 | 2004-12-09 | Kombinacija flupirtina in tramadola |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US7553858B2 (sl) |
| EP (1) | EP1697005B1 (sl) |
| JP (1) | JP4933265B2 (sl) |
| CN (1) | CN1889996A (sl) |
| AT (1) | ATE525112T1 (sl) |
| AU (1) | AU2004298333B2 (sl) |
| CA (1) | CA2546302C (sl) |
| DK (1) | DK1697005T3 (sl) |
| ES (1) | ES2373957T3 (sl) |
| HR (1) | HRP20110914T1 (sl) |
| MX (1) | MXPA06006999A (sl) |
| NO (1) | NO335734B1 (sl) |
| NZ (1) | NZ547256A (sl) |
| PL (1) | PL1697005T3 (sl) |
| PT (1) | PT1697005E (sl) |
| RU (1) | RU2463042C2 (sl) |
| SI (1) | SI1697005T1 (sl) |
| WO (1) | WO2005058420A1 (sl) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1789028A2 (en) * | 2004-08-24 | 2007-05-30 | Neuromolecular Pharmaceuticals Inc | Compositions for treating nociceptive pain |
| US7619007B2 (en) | 2004-11-23 | 2009-11-17 | Adamas Pharmaceuticals, Inc. | Method and composition for administering an NMDA receptor antagonist to a subject |
| JP5666087B2 (ja) | 2005-04-06 | 2015-02-12 | アダマス・ファーマシューティカルズ・インコーポレーテッド | Ｃｎｓ関連疾患の治療のための方法及び組成物 |
| US9434680B2 (en) * | 2007-04-27 | 2016-09-06 | Paratek Pharmaceuticals, Inc. | Methods for synthesizing and purifying aminoalkyl tetracycline compounds |
| US20120059024A1 (en) * | 2009-01-30 | 2012-03-08 | Relevare Aust. Pty Ltd | Drug abuse deterrent, methods and compositions |
| DE102010063609A1 (de) | 2010-12-20 | 2012-06-21 | Awd.Pharma Gmbh & Co. Kg | Neue Multikomponentenkristalle aus ([2-Amino-6-(4-fluoro-benzylamino)-pyridin-3yl)-carbamidsäureethylester und einer Arylpropionsäure |
| DE102010063612A1 (de) | 2010-12-20 | 2012-06-21 | Awd.Pharma Gmbh & Co. Kg | Neue Multikomponentenkristalle aus ([2-Amino-6-(4-fluoro-benzylamino)-pyridin-3-yl]-carbamidsäureethylester und 2-[2-[(2,6-Dichlorphenyl)-amino]-phenyl]-essigsäure |
| NZ628867A (en) * | 2012-03-02 | 2016-03-31 | Meda Pharma Gmbh & Co Kg | Pharmaceutical formulation containing flupirtine |
| US9693949B1 (en) | 2015-12-22 | 2017-07-04 | Revogenex Ireland Ltd | Intravenous administration of tramadol |
| US9980900B2 (en) | 2015-12-22 | 2018-05-29 | Revogenex Ireland Ltd | Intravenous administration of tramadol |
| RU2678976C1 (ru) * | 2018-03-21 | 2019-02-05 | федеральное государственное бюджетное образовательное учреждение высшего образования "Тверской государственный медицинский университет" Министерства здравоохранения Российской Федерации | Способ профилактики длительного болевого синдрома в отдаленном послеоперационном периоде у пациентов с дисплазией соединительной ткани |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0532627A (ja) * | 1991-07-29 | 1993-02-09 | Asta Medica Ag | 筋肉痙攣により帰因するか又は筋肉痙攣の結果である疾病及び症候群を治療するための医薬品及びその製法 |
| DE4236752A1 (de) * | 1992-10-30 | 1994-05-05 | Asta Medica Ag | Kombinationspräparat aus Flupirtin und Morphin zur Behandlung von Schmerzen und zur Vermeidung der Morphin-Abhängigkeit |
| DE19807535A1 (de) * | 1998-02-21 | 1999-08-26 | Asta Medica Ag | Pharmazeutische Kombinationen mit Tramadol |
| CZ2002411A3 (cs) * | 1999-08-03 | 2003-03-12 | Awd. Pharma Gmbh & Co. Kg | Farmaceutický prostředek pro léčení bolesti stejně jako prevenci chronických bolestí při degenerativních chorobách kloubů u psů a koček |
| RU2218189C1 (ru) * | 2002-05-28 | 2003-12-10 | Нижегородская государственная медицинская академия | Способ лечения мигрени в межприступном периоде заболевания |
-
2004
- 2004-12-03 US US11/002,762 patent/US7553858B2/en not_active Expired - Fee Related
- 2004-12-09 CA CA2546302A patent/CA2546302C/en not_active Expired - Fee Related
- 2004-12-09 AU AU2004298333A patent/AU2004298333B2/en not_active Ceased
- 2004-12-09 PL PL04803682T patent/PL1697005T3/pl unknown
- 2004-12-09 ES ES04803682T patent/ES2373957T3/es active Active
- 2004-12-09 NZ NZ547256A patent/NZ547256A/en unknown
- 2004-12-09 CN CNA2004800366436A patent/CN1889996A/zh active Pending
- 2004-12-09 MX MXPA06006999A patent/MXPA06006999A/es active IP Right Grant
- 2004-12-09 SI SI200431786T patent/SI1697005T1/sl unknown
- 2004-12-09 WO PCT/EP2004/014025 patent/WO2005058420A1/en active Application Filing
- 2004-12-09 DK DK04803682.6T patent/DK1697005T3/da active
- 2004-12-09 JP JP2006544286A patent/JP4933265B2/ja not_active Expired - Fee Related
- 2004-12-09 PT PT04803682T patent/PT1697005E/pt unknown
- 2004-12-09 EP EP04803682A patent/EP1697005B1/en active Active
- 2004-12-09 RU RU2006125520/15A patent/RU2463042C2/ru not_active IP Right Cessation
- 2004-12-09 AT AT04803682T patent/ATE525112T1/de active
-
2006
- 2006-07-17 NO NO20063308A patent/NO335734B1/no not_active IP Right Cessation
-
2011
- 2011-12-06 HR HR20110914T patent/HRP20110914T1/hr unknown
Also Published As
| Publication number | Publication date |
|---|---|
| NO335734B1 (no) | 2015-02-02 |
| RU2463042C2 (ru) | 2012-10-10 |
| MXPA06006999A (es) | 2006-12-14 |
| WO2005058420A1 (en) | 2005-06-30 |
| AU2004298333A1 (en) | 2005-06-30 |
| RU2006125520A (ru) | 2008-01-27 |
| HRP20110914T1 (hr) | 2011-12-31 |
| PL1697005T3 (pl) | 2012-02-29 |
| EP1697005A1 (en) | 2006-09-06 |
| NZ547256A (en) | 2009-04-30 |
| DK1697005T3 (da) | 2011-12-12 |
| CA2546302A1 (en) | 2005-06-30 |
| PT1697005E (pt) | 2011-12-29 |
| JP4933265B2 (ja) | 2012-05-16 |
| CA2546302C (en) | 2012-05-22 |
| NO20063308L (no) | 2006-09-12 |
| AU2004298333B2 (en) | 2009-12-17 |
| US7553858B2 (en) | 2009-06-30 |
| US20050137235A1 (en) | 2005-06-23 |
| EP1697005B1 (en) | 2011-09-21 |
| ATE525112T1 (de) | 2011-10-15 |
| CN1889996A (zh) | 2007-01-03 |
| JP2007514672A (ja) | 2007-06-07 |
| ES2373957T3 (es) | 2012-02-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20063308L (no) | Kombinasjon av flupirtin og tramadol | |
| PL367277A1 (en) | Methods of making sustained release formulations of oxymorphone related applications | |
| RS50876B (sr) | Upotreba flibanserina u lečenju seksualnih poremećaja | |
| NO2012009I2 (no) | Kombinasjonsprodukt av saxaglipin og metformin og farmasøytisk akseptable salter derav, herunder HCIsaltene av saxaglipin og metformin | |
| MY152846A (en) | New salts of valsartan | |
| HK1075843A1 (en) | 1-phenyl-2-dimethylaminomethyl cyclohexane compounds used for the therapy of depressive symptoms, pain, and incontinence | |
| AU2002332488A8 (en) | R-bambuterol, its preparation and therapeutic uses | |
| WO2005007149A8 (de) | Ambroxol für die behandlung akuter schmerzen | |
| GB0213869D0 (en) | The treatment of pain | |
| UA83821C2 (ru) | Производные бензолсульфонамидов, способ их получения и их применение для лечения воспалительных заболеваний и утоления боли | |
| HK1073779A1 (en) | The use of darifenacin and the salt thereof | |
| SI1408964T1 (sl) | Uporaba 2- 5-(4-fluorofenil)-3-piridilmetil-aminometil -kromana in njegovih fizioloĺ ko sprejemljivih soli | |
| IL158186A0 (en) | Pharmaceutically active compounds and methods of use | |
| AU2562501A (en) | Use of melagatran for manufacture of a medicament for the treatment of ischemic disorders | |
| UY26990A1 (es) | Nuevas composiciones de medicamentos | |
| GR1004434B (el) | Χρησηατουαdiclofenacαhααποδεκτωνααλατωνααυτουαγιαατηνααντιμετωπισηατωναεγκαυματων | |
| UA83017C2 (uk) | Комбінація рофлуміласту та r,r-формотеролу для лікування захворювань дихальних шляхів | |
| GEP20084463B (en) | Use of the distrontium salt of the acid 2-[n,n-di(carboxy methyl) amino]-3-cyano-4-carboxymethyl-thiophene-5-carboxylate for the production of medicaments for the treatment of gastro-duodenal pain | |
| MXPA03010919A (es) | Uso de acetil l-carnitina para preparacion de medicamento para terapia preventiva del dolor. | |
| AU2003290363A8 (en) | Therapeutic use of selective noradrenaline reuptake inhibitors | |
| PL367628A1 (en) | Use of an alkanoyl l-carnitine for the preparation of a medication to treat anhedonia | |
| SI1560578T1 (sl) | Uporaba distroncijeve soli 2-(n,n-di(karboksimetil)amino)-3-ciano-4- karboksimetiltiofen-5-karboksilne kisline za pripravo zdravil za zdravljenje gastro-duodenalnih bolecin | |
| GB0216978D0 (en) | The treatment of pain | |
| GB0216128D0 (en) | New therapeutic use | |
| GB0220064D0 (en) | New therapeutic use |